“哮喘与过敏性炎症”特刊
Special Issue on 'Asthma and Allergic Inflammation'.
作者信息
Pelaia Corrado
机构信息
Department of Health Sciences, University "Magna Græcia" of Catanzaro, 88100 Catanzaro, Italy.
出版信息
Vaccines (Basel). 2023 Feb 23;11(3):531. doi: 10.3390/vaccines11030531.
Abstract
Asthma is a chronic inflammatory airway disease, driven by either allergic or non-allergic stimuli, which usually manifests as wheezing, reversible airflow limitation, and bronchial hyperresponsiveness [...].
摘要
哮喘是一种慢性炎症性气道疾病，由过敏性或非过敏性刺激引发，通常表现为喘息、可逆性气流受限和支气管高反应性[...]。
相似文献
1
Special Issue on 'Asthma and Allergic Inflammation'.“哮喘与过敏性炎症”特刊
Vaccines (Basel). 2023 Feb 23;11(3):531. doi: 10.3390/vaccines11030531.
2
[Airway hyperresponsiveness in bronchial asthma].[支气管哮喘中的气道高反应性]
Nihon Kokyuki Gakkai Zasshi. 1998 Jul;36(7):569-76.
3
[Bronchial hyperreactivity other than that seen in asthma].[除哮喘中所见之外的支气管高反应性]
Rev Mal Respir. 1994;11(2):179-87.
4
Airway inflammation in asthma and chronic obstructive pulmonary disease with special emphasis on the antigen-presenting dendritic cell: influence of treatment with fluticasone propionate.哮喘和慢性阻塞性肺疾病中的气道炎症，特别强调抗原呈递树突状细胞：丙酸氟替卡松治疗的影响
Clin Exp Allergy. 1999 Jun;29 Suppl 2:116-24. doi: 10.1046/j.1365-2222.1999.00020.x.
5
[Bronchial hyperresponsiveness and its importance for the clinician].[支气管高反应性及其对临床医生的重要性]
Rev Med Suisse. 2014 Nov 19;10(451):2190-2, 2194-5.
6
Allergic bronchial asthma: airway inflammation and hyperresponsiveness.变应性支气管哮喘：气道炎症与高反应性。
Intern Med. 2003 Aug;42(8):636-43. doi: 10.2169/internalmedicine.42.636.
7
Bronchoprovocation Testing in Asthma: An Update.哮喘中的支气管激发试验：最新进展
Immunol Allergy Clin North Am. 2018 Nov;38(4):545-571. doi: 10.1016/j.iac.2018.06.010.
8
[Diseases to differentiate from COPD, with emphasis on bronchial asthma].[需与慢性阻塞性肺疾病相鉴别的疾病，重点是支气管哮喘]
Nihon Rinsho. 2007 Apr;65(4):675-81.
9
[Non-allergic factors of bronchial asthma].[支气管哮喘的非变应性因素]
Recenti Prog Med. 1989 Feb;80(2):99-106.
10
Pharmacological OGG1 inhibition decreases murine allergic airway inflammation.药理学上抑制OGG1可减轻小鼠过敏性气道炎症。
Front Pharmacol. 2022 Oct 17;13:999180. doi: 10.3389/fphar.2022.999180. eCollection 2022.
引用本文的文献
1
[Tezepelumab: a new option for the treatment of severe asthma].[tezepelumab：治疗重度哮喘的新选择]
Rev Med Inst Mex Seguro Soc. 2023 Nov 6;61(6):841-848. doi: 10.5281/zenodo.10064422.
本文引用的文献
1
The role of dendritic cells in allergic diseases.树突状细胞在过敏性疾病中的作用。
Int Immunopharmacol. 2022 Dec;113(Pt B):109449. doi: 10.1016/j.intimp.2022.109449. Epub 2022 Nov 17.
2
Cigarette smoke aggravates asthma by inducing memory-like type 3 innate lymphoid cells.香烟烟雾通过诱导记忆样 3 型先天淋巴细胞加重哮喘。
Nat Commun. 2022 Jul 4;13(1):3852. doi: 10.1038/s41467-022-31491-1.
3
Insights into the biology of IL-9 in asthma.哮喘中白细胞介素-9生物学特性的研究进展
J Allergy Clin Immunol. 2022 Sep;150(3):585-586. doi: 10.1016/j.jaci.2022.05.015. Epub 2022 Jun 2.
4
Paucigranulocytic Asthma: Potential Pathogenetic Mechanisms, Clinical Features and Therapeutic Management.少粒细胞性哮喘：潜在的发病机制、临床特征及治疗管理
J Pers Med. 2022 May 23;12(5):850. doi: 10.3390/jpm12050850.
5
Novel Biological Therapies for Severe Asthma Endotypes.针对重度哮喘内型的新型生物疗法。
Biomedicines. 2022 May 4;10(5):1064. doi: 10.3390/biomedicines10051064.
6
Respiratory Viral and Bacterial Factors That Influence Early Childhood Asthma.影响幼儿哮喘的呼吸道病毒和细菌因素
Front Allergy. 2021 Jul 22;2:692841. doi: 10.3389/falgy.2021.692841. eCollection 2021.
7
Immunoglobulin E response in health and disease beyond allergic disorders.免疫球蛋白 E 反应在健康和疾病中的作用超出过敏疾病。
Allergy. 2022 Jun;77(6):1700-1718. doi: 10.1111/all.15230. Epub 2022 Feb 1.
8
Discovering Biomarkers of Neutrophilic Asthma: A Clinician's Perspective.发现嗜中性粒细胞性哮喘的生物标志物：临床医生的视角
Allergy Asthma Immunol Res. 2022 Jan;14(1):1-4. doi: 10.4168/aair.2022.14.1.1.
9
Advances in asthma: New understandings of asthma's natural history, risk factors, underlying mechanisms, and clinical management.哮喘领域的进展：对哮喘自然史、危险因素、潜在机制及临床管理的新认识。
J Allergy Clin Immunol. 2021 Dec;148(6):1430-1441. doi: 10.1016/j.jaci.2021.10.001. Epub 2021 Oct 14.
10
The Role of Innate Lymphoid Cells in Chronic Respiratory Diseases.固有淋巴细胞在慢性呼吸系统疾病中的作用。
Front Immunol. 2021 Sep 22;12:733324. doi: 10.3389/fimmu.2021.733324. eCollection 2021.
Zotero 插件